Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC

Clinical trial NCT00314782 · COMPLETED

Trial details

NCT number: NCT00314782
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2006-03-01
Primary completion: 2008-03-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.